8-bromo cyclic adenosine monophosphate and Diabetes Mellitus, Type 2

8-bromo cyclic adenosine monophosphate has been researched along with Diabetes Mellitus, Type 2 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attie, AD; Bhatnagar, S; Clee, SM; Keller, MP; Oler, AT; Rabaglia, ME; Schueler, KL; Stapleton, DS; Stoehr, JP; Thurmond, DC; Truchan, NA; Worzella, SL; Yandell, BS1
Kurland, IJ; Pei, L; Tontonoz, P; Vaitheesvaran, B; Waki, H; Wilpitz, DC1
Eriksson, JW; Jansson, PA; Posner, BI; Smith, U; Yu, ZW1
Chaves, MM; Costa, DC; Lima E Silva, FC; Lima E Silva, R; Medina, LO; Nogueira-Machado, JA1

Other Studies

4 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Diabetes Mellitus, Type 2

ArticleYear
Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion.
    PLoS genetics, 2011, Volume: 7, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adaptor Proteins, Vesicular Transport; Animals; Chromosome Mapping; Cloning, Molecular; Diabetes Mellitus, Type 2; Disease Models, Animal; Genetic Predisposition to Disease; Glucose; HEK293 Cells; Humans; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Leptin; Mice; Mice, Inbred C57BL; Polymorphism, Single Nucleotide; Qa-SNARE Proteins; Quantitative Trait Loci; R-SNARE Proteins; Rats; SNARE Proteins; Syntaxin 1

2011
NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism.
    Nature medicine, 2006, Volume: 12, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperglycemia; Liver; Male; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Transcription Factors

2006
Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Diabetologia, 1997, Volume: 40, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Adrenergic beta-Agonists; Adult; Animals; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Insulin; Isoproterenol; Lipolysis; Male; Mice; Middle Aged; Phosphorylation; Receptor, Insulin; Tyrosine; Vanadates

1997
Effect in vitro of cyclic nucleotides-elevating agents on nitric oxide production by human granulocytes from type 2-diabetic patients.
    Diabetes & metabolism, 2002, Volume: 28, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aged; Cyclic AMP; Cyclic GMP; Diabetes Mellitus, Type 2; Female; Granulocytes; Humans; Male; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Reference Values

2002